+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

GSK

GSKNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$34.03

-0.03-0.09%

At close: -

$34.12

0.090.26%

After Hours: Dec 24, 3:32 PM EDT

GSK (GSK) Forecast

News

Earnings GSK (GSK) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for GSK (NYSE:GSK) Stock

GSK Stock (NYSE: GSK)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, December 23, 2024

Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
Anusuya Lahiri

Friday, December 20, 2024

GSK Announced Headline Results From FIRST-ENG...
Benzinga Newsdesk

Thursday, December 19, 2024

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh

Wednesday, December 18, 2024

CA Governor Newsom Proclaimed State Of Emerge...
Benzinga Newsdesk
CDC Confirms First Severe Case Of H5N1 Bird F...
Benzinga Newsdesk

Monday, December 16, 2024

What's Going On With Moderna Stock On Monday?
Vandana Singh
GSK Announces The U.S. FDA Has Granted Breakt...
Benzinga Newsdesk
The Committee For Medicinal Products For Huma...
Benzinga Newsdesk

Friday, December 13, 2024

Kennedy's Lawyer Urges FDA To Revoke Polio Vaccine Approval, Endangering Millions Of Children
Maureen Meehan
Bird Flu Spreads To Cats, Possibly Horses As Officials Signal No Plans To Authorize Vaccination
Hayden Buckfire
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Vandana Singh

Thursday, December 12, 2024

Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Vandana Singh

Tuesday, December 10, 2024

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
Vandana Singh

Monday, December 09, 2024

GSK shares are trading higher. GSK's DREAMM-7...
Benzinga Newsdesk
GSK's DREAMM-7 Trial Shows Sustained Overall ...
Benzinga Newsdesk
GSK's Blenrep Combination Secures Priority Re...
Benzinga Newsdesk
Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
Avi Kapoor
The FDA Has Accepted For Review GSK's Nucala ...
Benzinga Newsdesk

Friday, December 06, 2024

CNBC Halftime Report Final Trades: Oracle, Ve...
Benzinga Newsdesk
Reuters Agriculture & Energy Policy Reporter ...
Benzinga Newsdesk

Wednesday, November 27, 2024

GSK's Fully Liquid Menveo Meningococcal Vacci...
Benzinga Newsdesk

Tuesday, November 26, 2024

Bird Flu Found In Raw Milk Leads To Recall In California
Erica Kollmann
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
Vandana Singh

Wednesday, November 20, 2024

Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
Hayden Buckfire

Tuesday, November 19, 2024

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
Vandana Singh
GSK Announces Its GLISTEN Study Met Its Prima...
Benzinga Newsdesk

Monday, November 18, 2024

U.S. CDC Says Since April Confirmed Avian Inf...
Benzinga Newsdesk

Friday, November 15, 2024

European And US Vaccine Stocks Are Under Pressure - Here's WHy
Vandana Singh

Thursday, November 14, 2024

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
Vandana Singh

Wednesday, November 13, 2024

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Vandana Singh

Tuesday, November 12, 2024

Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
Vandana Singh
Jefferies Downgrades GSK to Hold
Benzinga Newsdesk

Monday, November 11, 2024

ViiV Healthcare's DOLCE Study Shows 2-Drug Re...
Benzinga Newsdesk

Thursday, November 07, 2024

Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
Erica Kollmann
GSK, Pfizer And Shionogi's ViiV Healthcare Ex...
Benzinga Newsdesk

Tuesday, November 05, 2024

GSK's AREXVY Vaccine Receives Expanded Approv...
Benzinga Newsdesk

Thursday, October 31, 2024

Guggenheim Downgrades GSK to Neutral
Benzinga Newsdesk

Wednesday, October 30, 2024

USDA Says H5N1 Bird Flu Detected In Swine For...
Benzinga Newsdesk
USDA To Begin Bulk Milk Testing For Bird Flu ...
Benzinga Newsdesk
GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
Vandana Singh
GSK shares are trading lower after the compan...
Benzinga Newsdesk
GSK Reaffirms Its 2024 Outlook, Sees Turnover...
Benzinga Newsdesk
GSK Q3 2024 Adj. EPS $1.29 Beats $1.23 Estima...
Benzinga Newsdesk

Tuesday, October 29, 2024

US CDC Reports 36 H5 Bird Flu Cases In U.S. S...
Benzinga Newsdesk
GSK Acquires CMG1A46 From Chimagen Bioscience...
Benzinga Newsdesk

Monday, October 28, 2024

Google To Launch New "Sexual Health & Wellnes...
Benzinga Newsdesk
IDEAYA Biosciences Reveals Clearance Of Investigational New DrugApplication With FDA For Initiation Of Phase 1 Clinical Trial To Evaluate Werner Helicase Development Candidate IDE275
Suganya Shanmugam

Thursday, October 24, 2024

Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
Vandana Singh
CDC Issues Report On Missouri H5N1 Serology T...
Benzinga Newsdesk
GSK Announced New Preliminary Data For Arexvy...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved